Clinical Trials on Chronic Lymphocytic Leukemia in United States
Total 15459 results
-
Dana-Farber Cancer InstituteBeiGeneRecruitingChronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL)United States
-
Novartis PharmaceuticalsTerminatedChronic Lymphocytic Leukemia (CLL)United States
-
Hoffmann-La RocheCompletedA Study of MabThera (Rituximab) Plus Chlorambucil in Participants With Chronic Lymphocytic Leukemia.Lymphocytic Leukemia, ChronicUnited Kingdom
-
Duke UniversityCompletedAging | Chronic Lymphocytic LeukemiaUnited States
-
University of Michigan Rogel Cancer CenterWithdrawnChronic Lymphocytic Leukemia | Lymphoma, Small LymphocyticUnited States
-
SanofiCompletedLeukemia, Lymphocytic, ChronicBelgium, United States, Australia, France, Germany, Italy, Netherlands, Puerto Rico, United Kingdom
-
Eisai Inc.CompletedLeukemia, Lymphocytic, ChronicCanada, Australia, United States, Argentina, Brazil
-
Dana-Farber Cancer InstituteBrigham and Women's HospitalCompletedReduced Intensity Stem Cell Transplantation for Chronic Lymphocytic Leukemia Followed by VaccinationChronic Lymphocytic LeukemiaUnited States
-
Dana-Farber Cancer InstituteBrigham and Women's HospitalCompletedChronic Lymphocytic LeukemiaUnited States
-
M.D. Anderson Cancer CenterCelgene CorporationTerminatedChronic Lymphocytic LeukemiaUnited States
-
Innate PharmaTerminatedChronic Lymphocytic LeukemiaUnited States
-
M.D. Anderson Cancer CenterGenentech, Inc.; OSI PharmaceuticalsCompletedChronic Lymphocytic LeukemiaUnited States
-
Abramson Cancer Center of the University of PennsylvaniaWithdrawnChronic Lymphocytic LeukemiaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedLeukemiaUnited States
-
National Cancer Institute (NCI)CompletedChronic Lymphocytic LeukemiaUnited States
-
M.D. Anderson Cancer CenterGenentech, Inc.CompletedChronic Lymphocytic LeukemiaUnited States
-
Memorial Sloan Kettering Cancer CenterCelgene CorporationCompletedLeukemia | Chronic Lymphocytic LeukemiaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); FDA Office of Orphan Products DevelopmentCompletedLeukemia | Chronic Lymphocytic LeukemiaUnited States
-
M.D. Anderson Cancer CenterGenentech, Inc.CompletedChronic Lymphocytic LeukemiaUnited States
-
M.D. Anderson Cancer CenterGenzyme, a Sanofi CompanyTerminated
-
National Cancer Institute (NCI)CompletedChronic Lymphocytic LeukemiaUnited States
-
M.D. Anderson Cancer CenterBayerCompletedChronic Lymphocytic LeukemiaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)Completed
-
Boston Medical CenterCompleted
-
Memgen, LLCCompleted
-
Memgen, LLCCompletedChronic Lymphocytic LeukemiaUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)WithdrawnRecurrent Small Lymphocytic Lymphoma | Prolymphocytic Leukemia | Recurrent Non-Hodgkin Lymphoma | Recurrent Chronic Lymphocytic LeukemiaUnited States
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)Recruiting
-
Nicole LamannaActive, not recruitingChronic Lymphocytic LeukemiaUnited States
-
University of IowaNational Cancer Institute (NCI); Mayo Clinic; PfizerCompletedChronic Lymphocytic LeukemiaUnited States
-
Michael ChoiPharmacyclics LLC.Active, not recruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingChronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | Richter SyndromeUnited States
-
M.D. Anderson Cancer CenterCelgene CorporationActive, not recruitingLymphoma | LeukemiaUnited States
-
Precision BioSciences, Inc.CompletedLymphoma, Non-Hodgkin | Chronic Lymphocytic Leukemia | B-cell Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | B-cell Non Hodgkin Lymphoma | Leukemia, Lymphocytic, Chronic | Non-Hodgkin's Lymphoma, Relapsed | Non-Hodgkin's Lymphoma Refractory | Chronic Lymphoid Leukemia in RelapseUnited States
-
Northwell HealthBayerTerminated
-
Iovance Biotherapeutics, Inc.Active, not recruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingStage I Chronic Lymphocytic Leukemia | Stage II Chronic Lymphocytic Leukemia | Stage III Chronic Lymphocytic Leukemia | Stage IV Chronic Lymphocytic LeukemiaUnited States, Canada
-
National Cancer Institute (NCI)CompletedWaldenström Macroglobulinemia | Recurrent Small Lymphocytic Lymphoma | B-cell Chronic Lymphocytic Leukemia | Refractory Chronic Lymphocytic LeukemiaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)Completed
-
Aptevo TherapeuticsCompletedChronic Lymphocytic Leukemia (CLL)United States, Austria, Germany, Poland, Spain
-
Dana-Farber Cancer InstituteGlaxoSmithKline; Gilead SciencesActive, not recruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
M.D. Anderson Cancer CenterSanofiCompleted
-
Dartmouth-Hitchcock Medical CenterWithdrawnChronic Lymphocytic LeukemiaUnited States
-
Thomas KippsCelgene CorporationTerminatedChronic Lymphocytic LeukemiaUnited States
-
Thomas KippsBayerTerminatedChronic Lymphocytic LeukemiaUnited States
-
University of California, San DiegoCelgene CorporationCompletedChronic Lymphocytic Leukemia | CLLUnited States
-
M.D. Anderson Cancer CenterGlaxoSmithKlineCompleted
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); Astex Pharmaceuticals, Inc.CompletedLymphoma | LeukemiaUnited States
-
University of California, San DiegoPharmacyclics LLC.Active, not recruitingChronic Lymphocytic LeukemiaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Ziopharm OncologyCompletedAcute Lymphoblastic Leukemia | Non-Hodgkin Lymphoma | Minimal Residual Disease | Small Lymphocytic Lymphoma | Acute Biphenotypic Leukemia | Stage III Chronic Lymphocytic Leukemia | Stage IV Chronic Lymphocytic Leukemia | CD19 Positive | Blasts 5 Percent or More of Bone Marrow Nucleated CellsUnited States